Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Panel of micrornas that silence the MCL-1 gene and sensitize cancer cells to ABT-263

Panel of micrornas that silence the MCL-1 gene and sensitize cancer cells to ABT-263

US Patent 8742083 · Granted Jun 3, 2014

Estimated economic value: $102,543,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnostic methods for determining prognosis of non-small cell lung cancer2018
Diagnostic methods for determining prognosis of non-small cell lung cancer2018
iASPP phosphorylation and metastatic potential2018
Detection of chromosomal abnormalities associated with prognosis of non small ce2017
Detection of chromosomal abnormalities associated with prognosis of non small ce2017
Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods 2017
Diagnostic methods for determining prognosis of non-small cell lung cancer2016
Diagnostic methods for determining prognosis of non-small cell lung cancer2016
Diagnostic methods for determining prognosis of non-small cell lung cancer2016
Diagnostic methods for determining prognosis of non-small cell lung cancer2016
Methods and compositions for identifying, classifying and monitoring subject hav2015
Methods for assembling panels of cancer cell lines for use in testing the effica2015